TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• The ion channel TRPA1 is linked to lung adenocarcinoma (LUAD), but its function is unknown.
• Fibroblast growth factor receptor 2 (FGFR2) drives LUAD progression via its C-terminal proline-rich motif.
• Understanding TRPA1's role in LUAD is crucial for developing targeted therapies.

Purpose of the Study:

• To elucidate the mechanism by which TRPA1 influences LUAD progression.
• To investigate the interaction between TRPA1 and FGFR2 in LUAD.
• To identify regulatory mechanisms controlling TRPA1 activity during metastasis.

Main Methods:

• Protein-protein interaction assays to study TRPA1 and FGFR2 binding.
• Analysis of TRPA1 expression and activation in LUAD models.
• Exosome isolation and miRNA analysis from astrocytes and cancer cells.
• In vitro and in vivo metastasis models.

Main Results:

• TRPA1's N-terminal ankyrin repeats directly bind to FGFR2's C-terminal proline-rich motif, causing constitutive FGFR2 activation and promoting LUAD progression and metastasis.
• TRPA1 is downregulated in brain metastases.
• Astrocytes release exosomal miRNA-142-3p that targets and reduces TRPA1 levels in cancer cells, inhibiting metastasis.

Conclusions:

• TRPA1 directly binds and activates FGFR2, driving LUAD.
• Exosomal miRNA-142-3p from astrocytes acts as a tumor suppressor by inhibiting TRPA1, thus hindering brain metastasis.
• This study reveals a novel TRPA1-FGFR2 axis and an astrocyte-mediated mechanism against LUAD brain metastasis.